These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of hepatic cytochrome P450 during Listeria monocytogenes infection of the brain. Garcia Del Busto Cano E; Renton KW J Pharm Sci; 2003 Sep; 92(9):1860-8. PubMed ID: 12950004 [TBL] [Abstract][Full Text] [Related]
3. Xenobiotic-metabolizing enzymes in carp (Cyprinus carpio) liver, spleen, and head kidney following experimental Listeria monocytogenes infection. Chambras C; Marionnet D; Taysse L; Deschaux P; Moreau J; Bosgiraud C J Toxicol Environ Health A; 1999 Feb; 56(3):205-19. PubMed ID: 9973004 [TBL] [Abstract][Full Text] [Related]
4. Factors involved in the depression of hepatic mixed function oxidase during infections with Listeria monocytogenes. Azri S; Renton KW Int J Immunopharmacol; 1991; 13(2-3):197-204. PubMed ID: 2071296 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure. Dani M; Boisvert C; Michaud J; Naud J; Lefrançois S; Leblond FA; Pichette V Drug Metab Dispos; 2010 Mar; 38(3):357-60. PubMed ID: 20007296 [TBL] [Abstract][Full Text] [Related]
6. Factors involved in the down-regulation of cytochrome P450 during Listeria monocytogenes infection. Armstrong SG; Renton KW Int J Immunopharmacol; 1994 Sep; 16(9):747-54. PubMed ID: 7806432 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice. Armstrong SG; Renton KW Mol Pharmacol; 1993 Apr; 43(4):542-7. PubMed ID: 8379989 [TBL] [Abstract][Full Text] [Related]
8. Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium. Chaluvadi MR; Kinloch RD; Nyagode BA; Richardson TA; Raynor MJ; Sherman M; Antonovic L; Strobel HW; Dillehay DL; Morgan ET Drug Metab Dispos; 2009 Feb; 37(2):366-74. PubMed ID: 18971315 [TBL] [Abstract][Full Text] [Related]
9. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR. de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of pathogenesis in Listeria monocytogenes infection. V. Early imbalance in host energy metabolism during experimental listeriosis. McCallum RE; Sword CP Infect Immun; 1972 Jun; 5(6):863-71. PubMed ID: 4344093 [TBL] [Abstract][Full Text] [Related]
11. Oral exposure to Listeria monocytogenes in aged IL-17RKO mice: A possible murine model to study listeriosis in susceptible populations. Alam MS; Costales M; Cavanaugh C; Pereira M; Gaines D; Williams K Microb Pathog; 2016 Oct; 99():236-246. PubMed ID: 27574777 [TBL] [Abstract][Full Text] [Related]
12. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain. Renton KW; Nicholson TE J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228 [TBL] [Abstract][Full Text] [Related]
13. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats. Chen J; Robertson G; Field J; Liddle C; Farrell GC Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550 [TBL] [Abstract][Full Text] [Related]
14. Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates. Lepay DA; Steinman RM; Nathan CF; Murray HW; Cohn ZA J Exp Med; 1985 Jun; 161(6):1503-12. PubMed ID: 4009118 [TBL] [Abstract][Full Text] [Related]
15. A novel mouse model for phenytoin-induced liver injury: involvement of immune-related factors and P450-mediated metabolism. Sasaki E; Matsuo K; Iida A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T Toxicol Sci; 2013 Nov; 136(1):250-63. PubMed ID: 23986454 [TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis for the impact of hypercholesterolemia on expressions of hepatic drug transporters and metabolizing enzymes. Liu Y; Pu QH; Wu MJ; Yu C Xenobiotica; 2016 Oct; 46(10):940-7. PubMed ID: 26887802 [TBL] [Abstract][Full Text] [Related]
17. Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes. Camus-Randon AM; Raffalli F; Béréziat JC; McGregor D; Konstandi M; Lang MA Toxicol Appl Pharmacol; 1996 May; 138(1):140-8. PubMed ID: 8658503 [TBL] [Abstract][Full Text] [Related]
18. Hepatic drug metabolism and immunostimulation. Renton KW Toxicology; 2000 Jan; 142(3):173-8. PubMed ID: 10667888 [TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification. Howell L; Jenkins RE; Lynch S; Duckworth C; Kevin Park B; Goldring C Arch Toxicol; 2021 Jul; 95(7):2413-2430. PubMed ID: 34050779 [TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of the murine liver in response to a combined exposure to psychological stress and 7,12-dimethylbenz(a)anthracene. Flint MS; Hood BL; Sun M; Stewart NA; Jones-Laughner J; Conrads TP J Proteome Res; 2010 Jan; 9(1):509-20. PubMed ID: 19938878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]